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Abstract 49 
 50 
A key challenge in precise genome editing is the low efficiency of homology-directed 51 
repair (HDR).  Here we describe a strategy for increasing the efficiency of HDR in cells by 52 
using a chromatin donor template instead of a naked DNA donor template.  The use of 53 
chromatin, which is the natural form of DNA in the nucleus, increases the frequency of 54 
HDR-edited clones as well as homozygous editing. In addition, transfection of chromatin 55 
results in negligible cytotoxicity. These findings suggest that a chromatin donor template 56 
should be useful for a wide range of HDR applications such as the precise insertion or 57 
replacement of DNA fragments that contain the coding regions of genes. 58 
 59 
 60 
 61 
Impact Statement 62 
Precise genome editing by homology-directed repair occurs more efficiently with a 63 
chromatin donor template than with a naked DNA donor template. 64 
65 
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Introduction 66 
 67 
The ability to manipulate genomes precisely is revolutionizing the biological sciences (Doudna, 68 
2020). Of particular utility is the modification or insertion of customized DNA sequences at a 69 
specific genomic location by homology-directed repair (HDR) (Jasin and Rothstein, 2013). For 70 
genome engineering in cells, HDR typically involves the generation of a specifically targeted 71 
DNA double-strand break (DSB) in the presence of a homologous DNA donor template that 72 
contains the desired sequence to be modified or inserted (Urnov et al., 2005; Bedell et al., 2012; 73 
Jinek et al., 2012; Cong et al., 2013; Pickar-Oliver and Gersbach, 2019). 74 
 A key challenge in successful genome editing has been the low efficiency of HDR 75 
(Carroll, 2014; Harrison et al., 2014). For the generation of specific alterations in a short stretch 76 
of DNA (<50 nt), recently developed techniques such as base editing (Rees and Liu, 2018; 77 
Molla and Yang, 2019) and prime editing (Anzalone et al., 2019) have been shown to be highly 78 
effective. In addition, for the imprecise insertion of larger DNA fragments, homology-79 
independent approaches can be used (Auer et al., 2014; He et al., 2016, Suzuki et al., 2016). 80 
These powerful methods cannot, however, be used for the precise insertion or replacement of 81 
>50 bp DNA fragments, such as those containing the coding regions of genes. For such 82 
applications, we considered a different strategy for increasing the efficiency of HDR in cells. 83 
Based on our previous observation that homologous strand pairing, an early step in HDR, 84 
occurs more efficiently with a chromatin donor template than with a plain (naked) DNA donor 85 
template in vitro (Alexiadis and Kadonaga, 2002), we postulated that HDR in cells might 86 
similarly be more efficient with a chromatin relative to a naked DNA donor template. 87 
 In this study, we tested this idea by comparing the efficiency of HDR with chromatin 88 
versus naked DNA donor templates in conjunction with DSBs generated by the clustered 89 
regularly interspaced short palindromic repeats (CRISPR)-Cas9 system. We found that the 90 
overall HDR efficiency as well as the frequency of homozygous editing is enhanced by the use 91 
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of a chromatin donor template relative to a DNA donor template. We thus envision that a 92 
chromatin donor template, which resembles the natural form of DNA in the nucleus, could be 93 
widely used to increase the success of HDR-mediated applications, particularly those that 94 
involve the targeted insertion of DNA fragments such as the coding regions of genes. 95 
 96 
97 
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Results 98 
 99 
To ascertain whether the use of chromatin donor templates affects the efficiency of HDR in 100 
cells, we reconstituted three DNA donor templates (corresponding to the human GAPDH, 101 
RAB11A, and ACTB loci) into chromatin and tested the relative efficiencies of the targeted 102 
insertion of the GFP coding sequence with chromatin versus naked DNA versions of these 103 
templates (Figure 1 and Figure 1 – figure supplements 1–4). The chromatin was reconstituted 104 
by using salt dialysis methodology with plasmid DNA and purified core histones from Drosophila 105 
embryos, which contain a broad mixture of covalent modifications that have not been precisely 106 
resolved (Levenstein and Kadonaga, 2002). With standard CRISPR-Cas9 methodology and 107 
human MCF10A cells (non-tumorigenic epithelial cells derived from human mammary glands), 108 
we observed that the use of a chromatin donor template relative to a naked DNA donor template 109 
resulted in a 7.4-, 2.9-, and 2.3-fold increase (average of three biological replicates) in the 110 
directed insertion of GFP sequences at the GAPDH, RAB11A, and ACTB loci, respectively 111 
(Figures 1B, 1C, and 1D and Figure 1 – figure supplements 3 and 4). Thus, at three different 112 
loci (GAPDH, RAB11A, and ACTB) in human MCF10A cells, there was a higher efficiency of 113 
HDR-mediated GFP insertion with chromatin donor templates than with naked DNA donor 114 
templates. 115 
 For many applications of HDR, it is essential to modify all of the copies of the target gene. 116 
Therefore, to test the frequency of occurrence of precise homozygous gene editing in the diploid 117 
MCF10A cells, we carried out PCR analyses of the individual GFP-positive clones, and we 118 
observed a variable but consistently higher frequency of homozygous HDR insertions with 119 
chromatin donor templates than with naked DNA donor templates at all three loci (GAPDH, 120 
RAB11A, and ACTB) in MCF10A cells (Figure 2 and Figure 2 – figure supplements 1–5). At the 121 
GAPDH locus, the use of chromatin relative to naked DNA donor templates resulted in a 2.1-122 
fold increase in homozygous editing. At the RAB11A locus, there was a high frequency of 123 
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homozygous insertions with the naked DNA donor template, and the use of a chromatin donor 124 
template only slightly augments (1.1-fold increase) the percentage of homozygous clones. 125 
Strikingly, at the ACTB locus, homozygous insertions were observed only with a chromatin 126 
donor template. These findings thus show that the use of chromatin relative to naked DNA 127 
donor templates can increase the efficiency of homozygous editing. 128 
 We also observed imperfect editing, in which there was at least one improperly edited 129 
chromosome, as indicated by either the absence of an edited chromosome or the presence of a 130 
PCR product whose size is not consistent with that of an edited or wild-type chromosome. In 131 
addition, by performing long-range PCR as in Kosicki et al. (2018), we identified two apparently 132 
homozygous clones that contained one chromosome with a precisely edited allele and one 133 
chromosome with a large deletion at the other allele (Figure 2 – figure supplement 2). Hence, in 134 
the generation of homozygous clones, it is important to carry out both standard and long-range 135 
PCR analyses. 136 
 The overall efficiency of achieving homozygous editing in diploid MCF10A cells was 15-137 
fold (7.4 x 2.1) at the GAPDH locus, 3.2-fold (2.9 x 1.1) at the RAB11A locus, and large but not 138 
quantifiable at the ACTB locus, at which we saw homozygous editing only with a chromatin 139 
donor template. The ACTB locus serves as an example in which the use of a chromatin 140 
template relative to a naked DNA template was the difference between a successful and an 141 
unsuccessful HDR experiment. 142 
 To determine whether a chromatin donor template affects the efficiency of HDR in a 143 
different cell line, we examined the insertion of GFP sequences at the GAPDH locus in HeLa 144 
cells, which are human cervical adenocarcinoma cells that are widely used in biomedical 145 
research. HeLa cells are aneuploid and contain four copies of the GAPDH gene, which is 146 
located on chromosome 12. In these experiments, we observed that the use of a chromatin 147 
donor template results in a 2.3-fold increase (average of three biological replicates) in the 148 
efficiency of insertion of the GFP sequence in at least one GAPDH locus in HeLa cells (Figures 149 
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3A, 3B and Figure 3 – figure supplement 1). We then examined the formation of homozygous 150 
edited clones that are generated upon targeted insertion of the GFP sequence at all four copies 151 
of the GAPDH locus in HeLa cells. In this analysis, we found a substantial increase (5/18 clones 152 
versus 1/21 clones) in the efficiency of formation of homozygous clones with the use of a 153 
chromatin donor template instead of a naked DNA donor template (Figures 3C, 3D, and 3E and 154 
Figure 3 – figure supplement 2). Hence, these results show a strong enhancement of HDR by 155 
using a chromatin relative to a naked DNA donor template in HeLa cells. 156 
 We additionally tested the effect of varying the amount of donor template DNA (as 157 
chromatin or naked DNA) upon the efficiency of HDR (Figure 3 – figure supplement 3). To this 158 
end, we used 0.5, 1.0, and 1.5 times the mass of DNA as in a standard experiment with the 159 
GAPDH donor template in HeLa cells. At each of the three amounts of donor template, we 160 
consistently saw a higher efficiency of generation of GFP-positive cells with chromatin relative to 161 
naked DNA. Moreover, there was an increase in the fold-enhancement by chromatin as the 162 
amount of donor template was increased. We thus observed that a chromatin donor template 163 
functions better than a naked DNA donor template for HDR at different concentrations. 164 
 Because chromatin has rarely been used in cell transfection experiments, we also 165 
investigated the toxicity of chromatin relative to naked DNA in five different human cell lines 166 
(Figure 3 – figure supplement 4). These experiments revealed that chromatin is of comparable 167 
or lower toxicity to cells relative to naked DNA in transfection experiments. This low toxicity of 168 
chromatin to cells could be useful for HDR applications in which there is low cell viability after 169 
transfection. 170 
 171 
172 
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Discussion 173 
 174 
Here we show that the efficiency of HDR-mediated gene editing can be increased by using a 175 
chromatin donor template instead of a naked DNA donor template. Why is chromatin more 176 
effective as an HDR donor template than naked DNA? We suggest that chromatin, as the 177 
natural form of DNA in the eukaryotic nucleus, is the preferred substrate (relative to naked DNA) 178 
for the factors that mediate homologous recombination in cells. In previous biochemical studies, 179 
we and others found that eukaryotic Rad51 and Rad54, but not bacterial RecA, can mediate 180 
homologous strand pairing, an early step in HDR, with a chromatin donor template (Alexiadis 181 
and Kadonaga, 2002; Jaskelioff et al., 2003). Moreover, we observed that homologous strand 182 
pairing occurs more efficiently with a chromatin donor template than with a naked DNA donor 183 
template (Alexiadis and Kadonaga, 2002). Hence, the new findings on HDR with chromatin 184 
donor templates in cells are consistent with the results of the earlier biochemical studies on 185 
homologous strand exchange. 186 
 In general, a wide range of efficiencies of HDR has been observed in different cell types 187 
and with different methodologies. A common factor in these HDR experiments has been, 188 
however, the use of a non-chromatin donor template. In this work, we sought to focus 189 
specifically on directly comparing the relative efficiencies of HDR with chromatin versus naked 190 
DNA donor templates. In these experiments, we consistently observed a higher efficiency of 191 
HDR with chromatin relative to naked DNA. These effects include the increased efficiency of 192 
targeted insertion of GFP sequences in both loci of a diploid chromosome and in all loci of a 193 
tetraploid chromosome. These findings therefore suggest that the use of a chromatin donor 194 
template instead of a naked DNA donor template would be a broadly useful strategy for the 195 
precise insertion or replacement of DNA sequences via HDR with different methods. Moreover, 196 
transfection of chromatin donor templates, which can be simply prepared by salt dialysis 197 
methodology with purified DNA and core histones, does not affect cell viability. Thus, current 198 
 Cruz-Becerra and Kadonaga 
9 
methods for HDR can be easily adapted to include chromatin donor templates in place of their 199 
naked DNA counterparts. 200 
 In this regard, it is notable that we reconstituted chromatin by using native core histones 201 
from Drosophila embryos. These histones contain an undefined broad mixture of covalent 202 
histone modifications (Levenstein and Kadonaga, 2002). Because the core histones and their 203 
modifications are highly conserved throughout eukaryotes, it seems likely that similar results 204 
would be obtained with core histones from other sources. It is possible, however, that the 205 
magnitude of enhancement of HDR by chromatin could be further increased by variation of the 206 
core histone sequences and modifications. 207 
 In conclusion, although there are excellent techniques for the alteration of short (<50 bp) 208 
stretches of DNA (Rees and Liu, 2018; Molla and Yang, 2019; Anzalone et al., 2019), there 209 
remains a need for increasing the efficiency of the specific insertion or replacement of longer 210 
DNA segments that may contain sequences such as the coding regions of genes. We anticipate 211 
that chromatin donor templates might be particularly useful for such applications. In addition, we 212 
expect that many new gene editing techniques will be developed in the future, and that some of 213 
these methods will benefit from the use of chromatin donor templates. Furthermore, the low 214 
toxicity of chromatin to cells may be useful for many current and future methods. There is 215 
considerable potential to the use of the natural form of the donor template in gene editing 216 
experiments. It is our hope that these findings will advance the utility of precise genome editing 217 
in basic, translational, and clinical research. 218 
 219 
220 
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Materials and methods 221 
 222 
To ensure the reproducibility of the results, at least two biological replicates were performed for 223 
each experimental condition. The exact number of replicates of each experiment is indicated in 224 
its associated figure legend. 225 
 226 
DNA constructs 227 
CRISPR RNA (crRNA) sequences targeting the GAPDH, RAB11A, or ACTB loci were each 228 
inserted into the pU6-(BbsI)CBh-Cas9-T2A-mCherry vector (Addgene plasmid # 64324) as 229 
described (Ran et al., 2013). The crRNA sequences that were used are as follows: GAPDH, 230 
GAGAGAGACCCTCACTGCTG; RAB11A, GGTAGTCGTACTCGTCGTCG; ACTB, 231 
GGTGAGCTGCGAGAATAGCC. The donor template plasmid for the modification of the 232 
GAPDH locus was generated as follows. Two homology arm (HA) sequences (∼1 kb each) were 233 
PCR-amplified with Phusion polymerase (NEB) and genomic DNA (gDNA) from HeLa cells. The 234 
oligonucleotides that were used are as follows (the upper case letters are complementary to 235 
GAPDH or T2A-EGFP sequences): 5' HA, agagataagcttGGACACGCTCCCCTGACTT, 236 
agagatggatccCTCCTTGGAGGCCATGTGGG; 3' HA, tgatagggtaccCCTGCCACACTCAGTCCC, 237 
tgataggaattcGCTGGGGTTACAGGCGTGCG. The T2A-EGFP sequence was PCR-amplified 238 
from the PX461 plasmid (Addgene plasmid # 48140) with the following oligonucleotides: 239 
agagatggatccGAGGGCAGAGGAAGTCTGCT and agagatggtaccTTACTTGTACAGCTCGTCCA. 240 
Then, the three DNA fragments were sequentially subcloned into the pBluescript KS vector 241 
(Stratagene). The 3' HA sequence was inserted between the KpnI and EcoRI sites; the T2A-242 
EGFP sequence was inserted between the BamHI and the KpnI sites; and the 5' HA sequence 243 
was inserted between the HindIII and the BamHI sites. All restriction enzymes were from NEB. 244 
The donor template plasmid for the modification of the RAB11A locus was Addgene plasmid # 245 
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112012, and the donor template plasmid for the modification of the ACTB locus was Addgene 246 
plasmid # 87425. 247 
 248 
Chromatin reconstitution 249 
Native Drosophila core histones from embryos collected from 0 to 12 hours after egg deposition 250 
were purified as described (Fyodorov and Levenstein, 2002; Khuong et al., 2017). The donor 251 
repair template plasmids were purified with the HiSpeed plasmid kit (Qiagen). The optimal 252 
histone:DNA ratio for each donor repair template was determined by carrying out a series of 253 
reactions with different histone:DNA ratios and then assessing the quality of chromatin by the 254 
micrococcal nuclease digestion assay, as described (Fyodorov and Levenstein, 2002; Khuong 255 
et al., 2017). Chromatin was reconstituted with purified core histones by using the salt dialysis 256 
method (Stein, 1989; Fei et al., 2015). In a typical chromatin reconstitution reaction, 50 µg 257 
plasmid DNA and 50 µg core histones were combined in TE buffer (10 mM Tris-HCl, pH 8, 258 
containing 1 mM EDTA) containing 1 M NaCl in a total volume of 150 µL. The mixture was 259 
dialyzed at room temperature against the following buffers in the indicated order: 2 h in TE 260 
containing 0.8 M NaCl; 3 h in TE containing 0.6 M NaCl; 2.5 h in TE containing 50 mM NaCl. 261 
The quality of the resulting chromatin was assessed by using the micrococcal nuclease 262 
digestion assay, and the chromatin was stored at 4 ºC until use. 263 
 264 
Cell lines 265 
HeLa cells were a gift from Dr. Anjana Rao (La Jolla Institute for Immunology). MCF10A cells 266 
were a gift from Dr. Jichao Chen (The University of Texas MD Anderson Cancer Center). The 267 
MCF10A and HeLa cells were not authenticated. The MCF10A cells and HeLa cells were tested 268 
for mycoplasma and found to be negative for mycoplasma contamination. 269 
 270 
Cell culture 271 
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MCF10A cells (non-tumorigenic mammary epithelial cells) were maintained in DMEM/F-12 272 
medium (Gibco) supplemented with 20 ng/mL EGF, 500 ng/mL hydrocortisone (Sigma), 10 273 
µg/mL insulin (Sigma), 100 ng/mL cholera toxin (Sigma), 100 U/mL penicillin and 100 µ/mL 274 
streptomycin (Gibco), and 5% horse serum (Gibco) at 37 ºC and 5% CO2. HeLa cells (human 275 
cervical carcinoma cells), HT1080 cells (human fibrosarcoma cells), SW480 cells (human 276 
colorectal adenocarcinoma cells), and 293T cells (derived from primary human embryonic 277 
kidney cells) were maintained in DMEM, high glucose medium (Corning) supplemented with 278 
10% fetal bovine serum (Gibco) and 100 U/mL penicillin and 100 µ/mL streptomycin (Gibco) at 279 
37 ºC and 5% CO2. 280 
 281 
Cell transfection 282 
In each series of experiments, cell transfections with chromatin or DNA donor templates were 283 
performed by following standard protocols under exactly the same conditions. Transfection of 284 
HeLa cells was performed with Lipofectamine 3000 (Invitrogen) according to the manufacturer's 285 
recommendations.  Linear polyethylenimine (PEI 25K; 25,000 MW; Polysciences, Inc.) was 286 
used for transfection of MCF10A cells at a PEI:DNA mass ratio of 3:1. The transfections were 287 
performed as follows. 5x105 cells/well were plated in six well plates the day before transfection. 288 
For each CRISPR-Cas9 target locus, cells were co-transfected with equal amounts of the 289 
target-specific donor repair template (as free plasmid DNA or chromatin) and the Cas9 coding 290 
plasmid containing the target-specific single guide RNA sequence.  For HeLa cells, DNA (1.25 291 
µg) or chromatin (containing 1.25 µg of DNA) was used in each transfection (except for the 292 
experiment in Figure 3 – figure supplement 1, in which 1.25 µg of the Cas9 coding plasmid 293 
containing the single guide targeting the GAPDH locus was co-transfected with 0.625 µg, 1.25 294 
µg, or 1.875 µg of donor template DNA as naked DNA or chromatin); for MCF10A cells, DNA 295 
(1.5 µg) or chromatin (containing 1.5 µg of DNA) was used in each transfection. 296 
 297 
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FACS and flow cytometry analysis 298 
At 24 h post-transfection, cells were detached with 0.25% trypsin (Corning). After centrifugation, 299 
the cell pellets were resuspended in culture media containing 250 ng/mL DAPI (Sigma). 300 
mCherry-positive, DAPI-negative cells were sorted by FACS and collected in six well plates 301 
(HeLa cells; 100,000 cells/well) or 24 well plates (MCF10A cells; 30,000 cells/well). Then, the 302 
cells were passaged twice before the analysis of the expression of GFP by flow cytometry. 303 
GFP-positive single-cells were sorted by FACS into 96 well plates. To determine the percentage 304 
of GFP-positive cells, at least 100,000 cells of each condition were analyzed by flow cytometry 305 
with a BD FACSAria Fusion or a BD FACSAria2 instrument. The BD FACSDiva Software was 306 
used for data acquisition, and data analysis was performed with FlowJo version 10.6.1 (BD). 307 
 308 
Molecular analysis of the targeted loci 309 
Genomic DNA samples from wild-type cells as well as from independent GFP-positive clones 310 
were isolated with the Quick Extract DNA extraction solution (Lucigen) by following the 311 
manufacturer's recommendations, and were then subjected to PCR analysis. First, the 312 
occurrence of edited alleles was analyzed with primers that flank the 5' and 3' homology arm 313 
sequences (and thus do not contain sequences in the donor template) at the location in which 314 
the GFP DNA was inserted. The specific primers that were used are as follows: GAPDH, F1: 315 
TGACAACAGCCTCAAGATCATCAGG, R1: GATGGAGTCTCATACTCTGTTGCCT; RAB11A, 316 
F1: TGGGAAGTGGACATCATTGG, R1: GACCCTCCAATATGTTCTGT; ACTB, F1: 317 
AATGCTGCACTGTGCGGCGA, R1: ATGGCATGGGGGAGGGCATA. Then, genomic DNA 318 
from potentially homozygous GFP-positive clones was analyzed by long-range PCR analysis 319 
with LongAmp Hot Start Taq DNA Polymerase (NEB), as described by Kosicki et al. (2018). The 320 
primers that were used are as follows. GAPDH, F2: CTCCTGCAGTGATTTGTTTCTTCTT, R2: 321 
ACTCATTCTCCCAACACACATCAAA; RAB11A, F2: GCTTTATCTTCTTTTTGCTCACCTG, R2: 322 
GTGTCCCATATCTGTGCCTTTATTG; ACTB, F2: ATGAATAAAAGCTGGAGCACCCAA, R2: 323 
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TTGTGCAGCTATACGCAAGATTAAG. The locations of the PCR primers at the GAPDH, 324 
RAB11A, and ACTB loci are depicted in Figure 2 – figure supplement 1. To confirm the integrity 325 
of the homozygous clones obtained with chromatin donor templates, we determined the DNA 326 
sequences of three GAPDH clones and three ACTB clones across the insertion junctions and 327 
found that the GFP sequences were precisely inserted into the target sites in all six clones. 328 
 329 
Statistical analysis 330 
The two-tailed Welch t-test with alpha = 0.05 was performed by using GraphPad Prism version 331 
8.4.1 (GraphPad Software). 332 
 333 
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Figure Legends 416 
 417 
Figure 1.  The efficiency of HDR-mediated gene editing with CRISPR-Cas9 is higher with 418 
chromatin donor templates than with DNA donor templates. (A) Schematic outline of the 419 
workflow in the CRISPR-Cas9-mediated editing experiments with DNA or chromatin donor 420 
templates. The HDR-mediated insertion of the GFP sequence was directed to different loci as 421 
follows. Plasmid DNA containing the coding sequence for Cas9-T2A-mCherry and a target-422 
specific sgRNA sequence was co-transfected into different human cell lines with the 423 
corresponding HDR donor template as either DNA or chromatin. At 24 hours post-transfection, 424 
mCherry-positive cells were enriched by FACS and cultured for an additional 10 days. The 425 
expression of GFP was then analyzed by flow cytometry, and individual GFP-positive cells were 426 
sorted by FACS to generate independent clones. To determine whether there was partial or 427 
complete conversion of the multiple chromosomes containing the target genes, genomic DNA 428 
samples from each of several independent GFP-positive clones were analyzed by PCR. In 429 
addition, the precise integration of the GFP sequence at the target sites in representative edited 430 
clones was confirmed by DNA sequencing. These experiments were performed under standard 431 
CRISPR-Cas9 genome-editing conditions, as in Ran et al. (2013). (B) Flow cytometry analysis 432 
reveals an increase in GFP-positive cells with chromatin relative to DNA donor templates. HDR 433 
experiments were performed, as outlined in A with MCF10A cells and GAPDH, RAB11A, or 434 
ACTB donor templates. The population of GFP-positive cells was gated based on control cells 435 
that show no GFP expression (no donor template; upper panel; see also Figure 1 – figure 436 
supplement 3). Representative data from one out of three independent experiments are shown. 437 
The results of the other two biological replicates are in Figure 1 – figure supplement 4. The 438 
percentage of GFP-positive cells is indicated in each plot. FSC-A: forward scatter area. (C) 439 
Individual results from three independent experiments with each of the target loci. The data 440 
points from each independent experiment are designated with the same colored dots. The mean 441 
and standard deviation are indicated for each set of experiments. The p-values were determined 442 
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by using Welch's t test. **, p < 0.01; *, p < 0.05. The calculated p-values are as follows: p = 443 
0.0062 for the GAPDH data set; p = 0.017 for the RAB11A data set; p = 0.048 for the ACTB 444 
data set. (D) The use of chromatin relative to naked DNA donor templates results in a 2.3- to 445 
7.4-fold enhancement of GFP-positive cells. The data for each of three independent HDR 446 
experiments with each locus are shown. The bars represent mean and standard deviation for 447 
each locus. 448 
 449 
Figure 1 – figure supplement 1.  Schematic representations of the CRISPR-Cas9 target 450 
regions for HDR-mediated insertion of a GFP reporter sequence. (A) GAPDH locus. A DNA 451 
sequence that encodes the T2A self-cleaving peptide fused to the GFP protein (T2A-GFP, 452 
indicated in the figure as “GFP”) is inserted in exon 9 (E9) of the GAPDH locus. This results in 453 
the production of a GAPDH-T2A-GFP polypeptide that is spontaneously cleaved into separate 454 
GAPDH and GFP proteins. (B) RAB11A locus. The GFP sequence is inserted in the first exon 455 
(E1) of the RAB11A locus. This in-frame HDR-mediated insertion yields a GFP-RAB11A fusion 456 
protein. (C) ACTB locus. The monomeric enhanced GFP sequence (mEGFP; indicated as 457 
“GFP”) is inserted into the second exon (E2) of the ACTB locus. This in-frame HDR-mediated 458 
insertion results in a mEGFP-ACTB fusion protein. All three donor repair templates contain the 459 
desired insert sequence flanked by two homology arms of about 1 kb each. The dashed lines 460 
indicate the regions of homology between the HDR donor templates and the CRISPR-Cas9 461 
targeted loci. The black boxes represent coding regions, and white boxes represent 462 
untranslated regions. E, exon; HA, homology arm. 463 
 464 
Figure 1 – figure supplement 2. Reconstitution of plasmid DNA donor templates into 465 
chromatin. (A) Salt dialysis reconstitution of chromatin. The HDR donor template plasmids were 466 
reconstituted into chromatin with purified core histones by the salt dialysis method. (B) 467 
Micrococcal nuclease digestion analysis of chromatin reconstituted with purified components. 468 
Preparations of chromatin that were reconstituted with each of the HDR donor template 469 
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plasmids (which correspond to the GAPDH, RAB11A, and ACTB loci) were subjected to partial 470 
digestion with four different concentrations of micrococcal nuclease. The samples were 471 
deproteinized, and the resulting DNA fragments were resolved by agarose gel electrophoresis 472 
and visualized by staining with ethidium bromide. The arrows indicate the DNA bands that 473 
correspond to mono-, di-, tri-, tetra-, and pentanucleosomes. The DNA size markers (M) are the 474 
123-bp ladder (Millipore Sigma). 475 
 476 
Figure 1 – figure supplement 3. Flow cytometry analysis of MCF10A cells in control 477 
experimental conditions. (A) Untransfected cells. (B) Cells were transfected with a Cas9-T2A-478 
mCherry plasmid (lacking an sgRNA) in the absence of a donor template. (C) Cells were 479 
transfected with a Cas9-T2A-mCherry plasmid (lacking an sgRNA) in the presence of the 480 
indicated chromatin donor templates. GFP positive cells in B and C, were gated based on 481 
control cells that do not contain the GFP sequence (untransfected cells). The percentage of 482 
GFP-positive cells is indicated in each plot. Representative data from one out of three 483 
experiment is shown. FSC-A: forward scatter area. 484 
 485 
Figure 1 – figure supplement 4. Flow cytometry analyses of biological replicates of HDR-486 
mediated gene integration experiments in MCF10A cells. (A) Data from HDR experiment 2 with 487 
GAPDH, RAB11A, or ACTB donor templates. (B) Data from HDR experiment 3 with GAPDH, 488 
RAB11A, or ACTB donor templates. HDR experiments were performed as outlined in Figure 1A. 489 
GFP-positive cells were gated based on control cells that show no GFP expression (no donor 490 
template condition). 491 
 492 
Figure 2. The use of chromatin donor templates increases the efficiency of HDR-mediated 493 
homozygous gene editing relative to that seen with DNA donor templates. (A) PCR analysis of 494 
gDNA from MCF10A GFP-positive clones. Three independent HDR experiments were 495 
performed as shown in Figure 1A, and the gDNA from individual GFP-positive clones was 496 
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analyzed by PCR. The positions of the PCR amplification products from edited and wild-type 497 
alleles are indicated. The PCR products derived from control wild-type cells are also included 498 
(left lane of each panel). The asterisks indicate imperfect clones that appear to contain at least 499 
one improperly edited chromosome, as indicated by either the absence of an edited 500 
chromosome or the presence of a PCR product whose size is not consistent with that of an 501 
edited or wild-type chromosome. The positions of the primer pairs (F1, R1) in the PCR analysis 502 
of each locus are shown in Figure 2 – figure supplement 1. The results from a representative 503 
subset of the GFP-positive clones are shown. The complete set of PCR results are in Figure 2 – 504 
figure supplements 2, 3, and 5. (B) The percentages of GFP-positive homozygous clones in 505 
three independent HDR experiments at each of the target loci. The results from each 506 
independent experiment (with DNA versus chromatin donor templates) are denoted with a 507 
connector line. The p-values were determined by using Welch's t-test. The calculated p-values 508 
are as follows: p = 0.062, p = 0.56, and p = 0.17 for the GAPDH, RAB11A and ACTB data sets, 509 
respectively. (C) Summary of the PCR analysis. MCF10A cells are diploid, and each clone was 510 
classified as homozygous (with two precisely edited chromosomes), heterozygous (with one 511 
precisely edited chromosome and one wild-type chromosome), or imperfect, as defined in A. 512 
 513 
Figure 2 – figure supplement 1. Diagrams of the positions of the primer sets for the PCR 514 
analysis of GFP-positive clones at the GAPDH, RAB11A, and ACTB loci. (A) GAPDH locus. (B) 515 
RAB11A locus. (C) ACTB locus. The expected PCR product sizes with wild-type gDNA (dashed 516 
lines), the positions of the primers (F1, R1, F2, R2; black arrows), and the DNA insertion sites 517 
(green arrows) at each locus are indicated. Two primer pairs are shown for each locus: F1, 518 
forward primer 1; R1, reverse primer 1; F2, forward primer 2; R2, reverse primer 2. E, Exon. The 519 
HDR-mediated insertions increase the lengths of the PCR products by 771 bp, 732 bp, and 730 520 
bp at the GAPDH, RAB11A, and ACTB loci, respectively. 521 
 522 
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Figure 2 – figure supplement 2. PCR analysis of gDNA from GFP-positive clones at the 523 
GAPDH locus in MCF10A cells. (A) Clones (n = 54) collected from three independent HDR 524 
experiments with a DNA donor template. Lanes 1 to 15, 16 to 32, and 33 to 54 correspond to 525 
experiment 1, experiment 2, and experiment 3, respectively. (B) Clones (n = 52) collected from 526 
three independent HDR experiments with a chromatin donor template. Lanes 1 to 15, 16 to 34, 527 
and 35 to 52 correspond to experiment 1, experiment 2, and experiment 3, respectively. In 528 
panels A and B, the positions of the PCR amplification products from edited and wild-type 529 
alleles are indicated. Asterisks denote imperfect clones. Clones were classified as defined in the 530 
figure legend of Figure 2 of the main text. The triangles indicate imperfect clones (as assessed 531 
with long-range PCR analysis; see panel C, below) with an apparently homozygous genotype in 532 
the standard PCR analysis, as in panels A and B. (C) Long-range PCR analysis of homozygous 533 
candidate clones (n = 40). Clones collected from three independent HDR experiments with 534 
either a DNA donor template (lanes 1 to 13) or a chromatin donor template (lanes 14 to 40) 535 
were analyzed. These clones were preliminarily classified as homozygous based on the PCR 536 
analysis shown in A and B. Clones that have a deletion within a 14.0 kb region surrounding the 537 
target insertion site, as indicated by the presence of an additional PCR product that is smaller 538 
than that of the properly edited allele, are denoted with triangles. The PCR product (14.0 kb) 539 
from gDNA of wild-type cells is also shown. The positions of the primer pairs (F2, R2) for the 540 
PCR analyses (panels A–C) are depicted in Figure 2 – figure supplement 1A. DNA size 541 
markers: M1 (1 kb Plus DNA Ladder, Invitrogen); M2 (λ DNA-HindIII Digest, NEB); M3 542 
(bacteriophage T7 DNA digested with HindIII). (D) Frequency of occurrence of homozygous, 543 
heterozygous, and imperfect clones in three independent HDR experiments. n, number of 544 
clones analyzed. (E) Summary of the combined results at the GAPDH locus in MCF10A cells. 545 
The percentages were calculated based on the data for the GAPDH locus in Figure 2C. 546 
 547 
Figure 2 – figure supplement 3. PCR analysis of gDNA from GFP-positive clones at the 548 
RAB11A locus in MCF10A cells. (A) Clones (n = 89) collected from three independent HDR 549 
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experiments with a DNA donor template. Lanes 1 to 34, 35 to 54, and 55 to 89 correspond to 550 
experiment 1, experiment 2, and experiment 3, respectively. (B) Clones (n = 97) collected from 551 
three independent HDR experiments with a chromatin donor template. Lanes 1 to 34, 35 to 55, 552 
and 56 to 97 correspond to experiment 1, experiment 2, and experiment 3, respectively. In A 553 
and B, the positions of the PCR amplification products from edited and wild-type alleles are 554 
indicated. Asterisks indicate imperfect clones, as defined in the figure legend of Figure 2. (C) 555 
Frequency of occurrence of homozygous, heterozygous, and imperfect clones in each of three 556 
independent HDR experiments. n, number of clones analyzed. 557 
 558 
Figure 2 – figure supplement 4. Long-range PCR analysis of gDNA from GFP-positive clones 559 
at the RAB11A locus in MCF10A cells. (A) Analysis of homozygous candidates (n = 31) 560 
collected from three independent HDR experiments with a DNA donor template. (B) Analysis of 561 
homozygous candidates (n = 35) collected from three independent HDR experiments with a 562 
chromatin donor template. In panels A and B, the PCR product (14.91 kb) from gDNA of wild-563 
type cells is also shown. The positions of the primers (F2, R2) in the PCR analysis are depicted 564 
in Figure 2 – figure supplement 1B. DNA size markers: M1 (1 kb Plus DNA Ladder, Invitrogen); 565 
M2 (λ DNA-HindIII Digest, NEB); M3 (bacteriophage T7 DNA digested with HindIII). (C) 566 
Summary of the combined results at the RAB11A locus in MCF10A cells. The percentages were 567 
calculated based on the data for the RAB11A locus in Figure 2C. 568 
 569 
Figure 2 – figure supplement 5. PCR analysis of gDNA from GFP-positive clones at the ACTB 570 
locus in MCF10A cells. (A) Clones (n = 72) collected from three independent HDR experiments 571 
with a DNA donor template. Lanes 1 to 29, 30 to 48, and 49 to 72 correspond to experiment 1, 572 
experiment 2, and experiment 3, respectively. (B) Clones (n = 71) collected from three 573 
independent HDR experiments with a chromatin donor template. Lanes 1 to 31, 32 to 50, and 574 
51 to 71 correspond to experiment 1, experiment 2, and experiment 3, respectively. In A and B, 575 
the positions of the PCR amplification products from edited and wild-type alleles are indicated. 576 
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M, DNA size markers (1.65, 2, 3, 4, 5, 6 kb; 1 kb Plus DNA Ladder, Invitrogen). Asterisks 577 
denote imperfect clones as defined in Figure 2. (C) Frequency of occurrence of homozygous, 578 
heterozygous, and imperfect clones in three independent HDR experiments. n, number of 579 
clones analyzed. (D) Long-range PCR analysis of homozygous candidates collected from HDR 580 
experiments with a chromatin donor template. The PCR product (10.43 kb) from gDNA of wild-581 
type cells is also shown. The positions of the primers (F2, R2) in the PCR analysis are depicted 582 
in Figure 2 – figure supplement 1C. (E) Summary of the combined results at the ACTB locus in 583 
MCF10A cells. The percentages were calculated based on the data for the ACTB locus in 584 
Figure 2C. 585 
 586 
Figure 3. The efficiency of HDR-mediated gene editing with CRISPR-Cas9 is higher with a 587 
chromatin donor template than with a DNA donor template in HeLa cells. (A) The use of a 588 
chromatin donor template relative to a naked DNA donor template results in an increase of 589 
GFP-positive cells. HDR experiments were performed as depicted in Figure 1A with HeLa cells 590 
and the GAPDH locus donor template. The population of GFP-positive cells was gated based 591 
on control cells that show no GFP expression (no HDR donor; left panel). Representative data 592 
from one out of three independent experiments are shown. The results of the other two 593 
biological replicates are in Figure 3 – figure supplement 1. The percentage of GFP-positive cells 594 
is indicated in each plot. FSC-A: forward scatter area. (B) Individual results of flow cytometry 595 
analysis from three independent experiments with the GAPDH locus and HeLa cells. The data 596 
points from each independent experiment are designated with the same colored dots. The p-597 
value was determined by using Welch's t-test. ***, p < 0.0001. The mean and standard deviation 598 
are indicated. (C) The use of a chromatin HDR donor template results in an increase in the 599 
efficiency of homozygous edited clones relative to that seen with a DNA donor template. PCR 600 
analysis of edited genomic DNA was carried out as in Figure 2A. The positions of the PCR 601 
amplification products from edited and wild-type chromosomes are shown. The PCR products 602 
from control wild-type cells are also included (left lane). The results from a representative subset 603 
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of the GFP-positive clones are shown. The results from the other GFP-positive clones that were 604 
analyzed are in Figure 3 – figure supplement 2. (D) Summary of the PCR analysis of clones 605 
obtained in the HDR-mediated insertion of GFP sequences at the GAPDH locus in HeLa cells. 606 
The homozygous clones have four copies of the integrated GFP sequence, the heterozygous 607 
clones have one to three copies of the integrated GFP sequence, and the imperfect clones 608 
appear to contain improperly edited chromosomes, as indicated by either the absence of an 609 
edited chromosome or the presence of a PCR product whose size is not consistent with that of 610 
an edited or wild-type chromosome. (E) The percentages of GFP-positive homozygous clones 611 
in two independent HDR experiments. The results from each independent experiment (with 612 
DNA versus chromatin donor templates) are denoted with a connector line. 613 
 614 
Figure 3 – figure supplement 1. Flow cytometry analyses of biological replicates of HDR-615 
mediated gene integration experiments in HeLa cells. (A) Data from HDR experiment 2. (B) 616 
Data from HDR experiment 3. HDR experiments were performed as outlined in Figure 1A. GFP-617 
positive cells was gated based on cells that show no GFP expression (no HDR donor; left 618 
panels). 619 
 620 
Figure 3 – figure supplement 2. PCR analysis of gDNA from GFP-positive clones in HeLa 621 
cells. (A) Clones collected from HDR experiments with a DNA donor template (clones 12 to 21) 622 
or a chromatin donor template (clones 10 to 18). The positions of the PCR products of the wild-623 
type and HDR-edited alleles are indicated. The positions of the primer pairs (F1, R1) are 624 
depicted in Figure 2 – figure supplement 1A. The asterisks denote imperfect clones, as 625 
specified in the figure legend of Figure 2. M, DNA size marker (1 kb DNA ladder, Invitrogen). (B) 626 
Long-range PCR analysis of six homozygous clones collected from two independent HDR 627 
experiments. The PCR product (14.0 kb) from gDNA of wild-type cells is also shown. The 628 
positions of the primer pairs (F2, R2) are depicted in Figure 2 – figure supplement 1A. DNA size 629 
markers: M1 (1 kb Plus DNA Ladder, Invitrogen); M2 (λ DNA-HindIII Digest, NEB); M3 630 
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(bacteriophage T7 DNA digested with HindIII). (C) Frequency of occurrence of homozygous, 631 
heterozygous, and imperfect clones in two independent HDR experiments. n, number of clones 632 
analyzed. (D) Summary of the combined results at the GAPDH locus in HeLa cells. The 633 
percentages were calculated based on the data in Figure 3D. n, number of clones analyzed. 634 
 635 
Figure 3 – figure supplement 3. The efficiency of GFP insertion with different amounts of 636 
donor template in HeLa cells is higher with chromatin than with DNA. (A) The results from HDR 637 
experiment 1. (B) The results from HDR experiment 2. In A and B, the experiments were 638 
performed as depicted in Figure 1A. HeLa cells were co-transfected with the Cas9-T2A-639 
mCherry plasmid containing the sgRNA sequence targeting the GAPDH locus and 0.625 µg (+), 640 
1.25 µg (++), or 1.88 µg (+++) of the corresponding HDR donor template as either DNA or 641 
chromatin. As a reference, we used 1.25 µg (++) of donor template as DNA or chromatin in our 642 
standard experiments, such as those shown in the main figures. At 24 hours post-transfection, 643 
mCherry-positive cells were enriched by FACS and cultured for an additional 10 days. The 644 
expression of GFP was then analyzed by flow cytometry. (C) Summary of the results from HDR 645 
experiments 1 and 2. The percentages of GFP-positive cells in each experiment are shown. The 646 
mean and standard deviation (horizontal bars) are depicted for each experimental condition (n = 647 
2). 648 
 649 
Figure 3 – figure supplement 4. Chromatin templates are of comparable or lower toxicity to 650 
cells relative to naked DNA templates. Cell viability after transfection with a 3 kb plasmid as 651 
either naked DNA or chromatin was determined along with the viability of mock-transfected (no 652 
DNA or chromatin) cells. The cell viability was assessed by flow cytometry in the presence of 653 
DAPI (4',6-diamidino-2-phenylindole). The analysis was performed 48 h after transfection. The 654 
mean and standard deviation from at least two independent experiments with each cell line are 655 
shown. 656 
 657 
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PCR analysis of gDNA of MCF10A GFP-positive clones at the GAPDH locus
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PCR analysis of gDNA of MCF10A GFP-positive clones at the RAB11A locus
A B
W
ild
 ty
pe
GFP+ Clones
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Chromatin HDR Donor
W
ild
 ty
pe
4849 50
32 33 34
35 36 37 38 39 40 41 42 43 44
Edited
Wild type
Edited
Wild type
Edited
Wild type
Edited
Wild type
W
ild
 ty
pe
GFP+ Clones
18
19 20 21 22 23 24 25 26 27
W
ild
 ty
pe
45 46
28 29 30 31
R
A
B
11
A
W
ild
 ty
pe
GFP+ Clones
16 17 18 19 2021 22 23 242526 2728 2930 31 32
W
ild
 ty
pe
GFP+ Clones
1 2 3 4 5 6 7 8 9 10 11 12 13 14
15
W
ild
 ty
pe
GFP+ Clones
33 34
35 3637 38 39 40 4142 43 44 45 46 4748 49 50 51 52 5354
W
ild
 ty
pe
GFP+ Clones
R
A
B
11
A
DNA HDR Donor
1% Agarose Gel Electrophoresis
Edited
Wild type
Edited
Wild type
Edited
Wild type
Edited
Wild type
55 56 5758 59 60 6162 63 6465 66 6768
69 70
16 17
GFP+ Clones
47 51 52 53 54
GFP+ Clones
55
56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71
1% Agarose Gel Electrophoresis
GFP+ Clones
71 72 73 74 75 76 7778 79 80 81 82 8384 8586 87 88 89W
ild
 ty
pe
∗
∗ ∗ ∗∗ ∗ ∗ ∗
∗ ∗ ∗∗
∗
Edited
Wild type
∗ ∗ ∗ ∗∗
GFP+ Clones
74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89
72 73
W
ild
 ty
pe
GFP+ Clones
90 91 92 93 94 95 96 97W
ild
 ty
pe
Edited
Wild type
Edited
Wild type
Edited
Wild type
∗
∗
∗ ∗
∗ ∗ ∗
∗
∗
MCF10A Cells
GFP+ Clones (n = 89)
MCF10A Cells
GFP+ Clones (n = 97)
RAB11A Locus
MCF10A Cells
ChromDNA ChromDNA
0
20
40
60
80
100
Fr
eq
ue
nc
y 
(%
)
ChromDNA
56
21
24
59
35
6
35
40
25
43
14
51
34
14
55
10
43
36
Experiment 1 Experiment 3Experiment 2
Homozygous
Heterozygous
Imperfect
GFP+ Clones 
n = 34 n = 34 n = 20 n = 21 n = 35 n = 42
C
Cruz-Becerra & Kadonaga, Figure 2 – figure supplement 4
Long-range PCR analysis of gDNA of MCF10A GFP-positive clones at the RAB11A locus
A
B
C
MCF10A Cells 
GFP+ Clones (n = 31)
DNA HDR Donor
RAB11A Locus
ChromatinDNA
Fr
eq
ue
nc
y 
(%
)
49
30
20
54
37
90
20
40
60
80
100
MCF10A Cells
Homozygous
Heterozygous
Imperfect
MCF10A Cells 
GFP+ Clones (n = 35)
Chromatin HDR Donor
0.6% Agarose Gel Electrophoresis
W
ild
 ty
peHomozygous Candidates
1 2 3 4 5 6M
1
M
2
M
3
7 8 9 1011 12 13 14 15 16 17 1819 20
0.6% Agarose Gel Electrophoresis
Kb
16.1 
14.6 
5.6 
3.6 
Kb
16.1 
14.6 
5.6 
3.6 
W
ild
 ty
pe
21 22 23 24 25 26M
1
M
2
M
3
27 28 29 30 31
Homozygous Candidates
W
ild
 ty
peHomozygous Candidates
1 2 3 4 5 6M
1
M
2
M
3
7 8 9 1011 12 13 14 15 16 17 1819 20
Kb
16.1 
14.6 
5.6 
3.6 
Kb
16.1 
14.6 
5.6 
3.6 
W
ild
 ty
pe
21 22 23 24 25 26M
1
M
2
M
3
27 28 29 30 31
Homozygous Candidates
32 33 34 35
0.6% Agarose Gel Electrophoresis 0.6% Agarose Gel Electrophoresis
GFP+ Clones 
n = 89 n = 97
HDR Donor
Cruz-Becerra & Kadonaga, Figure 2 – figure supplement 5
PCR analysis of gDNA of MCF10A GFP-positive clones at the ACTB locus
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The efficiency of HDR-mediated gene editing with CRISPR-Cas9 is higher with
a chromatin donor template than with a DNA donor template in HeLa cells
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Flow cytometry analysis of biological replicates of HDR-mediated 
gene integration experiments in HeLa cells 
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The efficiency of GFP insertion with different amounts of donor template in HeLa cells
is higher with chromatin than with DNA
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Chromatin templates are of comparable or lower toxicity to cells
relative to naked DNA templates
